Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF June 7, 2013 | Archived Issues

P&T Committee Adds Medical-Grade Honey to Formulary

Pharmacy Focus

April's actions by the Pharmacy and Therapeutics Committee include the addition of medical-grade honey to the formulary. Also, the U.S. Food and Drug Administration is advising healthcare professionals against using magnesium sulfate injections for more than five to seven days to stop pre-term labor in pregnant women.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - May 2013 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

P&T Committee Adds Medical-Grade Honey to Formulary

Pharmacy Focus

April decisions by the Pharmacy and Therapeutics Committee and pertinent agenda topics are summarized in the PDF linked below. Highlights include the addition of medical-grade honey to the formulary and the removal of Santyl® from the formulary.

P and T Committee Approvals - April 9, 2013 (PDF)

FDA Recommends Against Prolonged Use of Magnesium Sulfate in Pregnant Women

The U.S. Food and Drug Administration is advising healthcare professionals against using magnesium sulfate injections for more than five to seven days to stop pre-term labor in pregnant women.

Administration of these injections to pregnant women longer than five to seven days may lead to low calcium levels and bone problems in the developing fetus, including osteopenia and fractures. The shortest duration of treatment that can result in harm to the baby is not known.

This use of the drug is off label and is not approved by the FDA. Magnesium sulfate is approved to prevent seizures in preeclampsia, a condition in which the pregnant woman develops high blood pressure and protein in the urine, and for control of seizures in eclampsia. Preeclampsia and eclampsia are life-threatening complications that can occur during pregnancy.

Click here for more information.